Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALT Altimmune, Inc.

已收盘 05-13 16:00:00 EDT

7.37

+0.15

+2.08%

盘后7.30

-0.07-0.95%

19:40 EDT

最高7.57	最低7.12	成交量219.92万
今开7.32	昨收7.22	日振幅6.30%
总市值5.23亿	流通市值5.18亿	总股本7,090万
成交额1,613万	换手率3.13%	流通股本7,033万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":7.37,"timestamp":1715630400000,"preClose":7.22,"halted":0,"volume":2199203,"hourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.37,"latestTime":"19:40 EDT","volume":72596,"amount":533553.6128,"timestamp":1715643606339},"delay":0,"floatShares":70334426,"shares":70902191,"eps":-1.588042,"marketStatus":"已收盘","marketStatusCode":5,"change":0.15,"latestTime":"05-13 16:00:00 EDT","open":7.32,"high":7.57,"low":7.115,"amount":16134823.3752055,"amplitude":0.063019,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.588042,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715673600000},"adr":0,"adjPreClose":7.22,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.26,"preClose":7.22,"latestTime":"09:27 EDT","volume":7886,"amount":57256.6523498,"timestamp":1715606870022},"postHourTrading":{"tag":"盘后","latestPrice":7.3,"preClose":7.37,"latestTime":"19:40 EDT","volume":72596,"amount":533553.6128,"timestamp":1715643606339},"volumeRatio":0.713735},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"2434861225","title":"摩根大通证券公司：维持Altimmune(ALT.US)评级，由优于大市调整至优于大市评级, 目标价由25.00美元调整至24.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434861225","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434861225?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:45","pubTimestamp":1715359510,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Altimmune(ALT.US)评级，由优于大市调整至优于大市评级, 目标价由25.00美元调整至24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100451587517ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100451587517ef1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434018694","title":"Altimmune, Inc.盘中异动 大幅拉升5.03%报7.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434018694","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434018694?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:35","pubTimestamp":1715261757,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时35分，Altimmune, Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报7.52美元/股，成交量18.7123万股，换手率0.26%，振幅4.29%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，再鼎医药、Notable Labs, Ltd.、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.、Alzamend Neuro, Inc.较为活跃，换手率分别为39.95%、13.21%、4.26%，振幅较大的相关个股有Notable Labs, Ltd.、180 Life Sciences Corp C/Wts 07/11/2025、Alzamend Neuro, Inc.，振幅分别为27.83%、21.74%、13.01%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921355887e86c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921355887e86c7d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433786908","title":"Altimmune Inc    预计每股亏损 37 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433786908","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433786908?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:39","pubTimestamp":1715092798,"startTime":"0","endTime":"0","summary":"   * Altimmune Inc     将于 5 月 9 日公布截至 0001 年 1 月 1 日的财报，预计季度收入将有所下降。*    * LSEG分析师对Altimmune公司的平均预期是每股亏损37美分。* 华尔街对 Altimmune Inc 的 12 个月目标价中位数为 25.00 美元，高于其最新收盘价 7.36 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432977057","title":"Altimmune, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432977057","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432977057?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743142,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分，Altimmune, Inc.股票出现异动，股价急速上涨5.01%。截至发稿，该股报7.55美元/股，成交量11.8056万股，换手率0.17%，振幅2.22%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Vaxxinity, Inc.、Ardelyx, Inc.、Jaguar Health, Inc.涨幅较大，Allarity Therapeutics, Inc.、Vaxxinity, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为62.01%、21.69%、10.64%，振幅较大的相关个股有Rani Therapeutics Holdings, Inc.、Organovo Holdings, Inc.、Relay Therapeutics, Inc.，振幅分别为15.86%、15.78%、13.56%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321322287e8577c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321322287e8577c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431032981","title":"Altimmune, Inc.盘中异动 股价大涨5.08%报6.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431032981","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431032981?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:37","pubTimestamp":1714484275,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时37分，Altimmune, Inc.股票出现波动，股价大幅上涨5.08%。截至发稿，该股报6.72美元/股，成交量28.0788万股，换手率0.40%，振幅6.02%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Senti Biosciences, Inc.、Vaccinex, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为554.58%、180.86%、10.23%，振幅较大的相关个股有Senti Biosciences, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为24.41%、17.57%、13.95%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430213755861ea6b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430213755861ea6b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431854268","title":"BUZZ-古根海姆下调 Altimmune 的评级，因为肥胖症药物 \"可能已经起航","url":"https://stock-news.laohu8.com/highlight/detail?id=2431854268","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431854268?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:46","pubTimestamp":1714394794,"startTime":"0","endTime":"0","summary":"    4月29日 - ** 药物开发商 Altimmune    股价盘前下跌 5.8% 至 6.84 美元 ** 券商Guggenheim将该股评级从 \"买入 \"下调至 \"中性\"，并取消了该股的PT评级 ** 在竞争日趋激烈的肥胖症和脂肪肝或代谢功能障碍相关性脂肪性肝炎 市场上，Guggenheim 认为，如果没有合作伙伴，ALT 没有令人信服的发展前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429791859","title":"Altimmune, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429791859","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429791859?lang=zh_cn&edition=full","pubTime":"2024-04-23 00:41","pubTimestamp":1713804114,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日00时41分，Altimmune, Inc.股票出现异动，股价快速上涨5.07%。截至发稿，该股报7.26美元/股，成交量84.6425万股，换手率1.19%，振幅5.64%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Moolec Science Sa、Nkgen Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为190.93%、84.40%、59.08%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Effector Therapeutics Inc C/Wts 31/12/2025 ，振幅分别为247.52%、82.14%、55.00%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230041547a549d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230041547a549d94&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424698380","title":"美国研究综述-Biomea Fusion、贝莱德、Capital Bancorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2424698380","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424698380?lang=zh_cn&edition=full","pubTime":"2024-04-02 16:00","pubTimestamp":1712044801,"startTime":"0","endTime":"0","summary":"    路透社4月2日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Biomea Fusion、贝莱德和 Capital Bancorp。要闻 * Biomea Fusion Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性 * 贝莱德  ：摩根大通将目标价从742美元上调至767美元 * Capital Bancorp Inc   ：斯蒂芬斯将其评级从 \"等权重 \"上调至 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0986},{"period":"3month","weight":-0.3084},{"period":"6month","weight":1.888},{"period":"1year","weight":0.3546},{"period":"ytd","weight":-0.3582}],"compareEarnings":[{"period":"1week","weight":0.0187},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0392},{"period":"6month","weight":0.1821},{"period":"1year","weight":0.2638},{"period":"ytd","weight":0.0958}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。Altimmune, Inc.是一家临床阶段的生物制药公司，专注于开发肥胖和肝病的治疗方法。他们的主要候选产品pemvidutide（以前称为ALT-801）是一种GLP-1/胰高血糖素双受体激动剂，正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎（“MASH”），以前称为非酒精性脂肪性肝炎。","yearOnYearQuotes":[{"month":1,"riseRate":0.411765,"avgChangeRate":-0.003942},{"month":2,"riseRate":0.352941,"avgChangeRate":-0.000026},{"month":3,"riseRate":0.411765,"avgChangeRate":-0.040906},{"month":4,"riseRate":0.352941,"avgChangeRate":-0.055497},{"month":5,"riseRate":0.470588,"avgChangeRate":0.063363},{"month":6,"riseRate":0.4375,"avgChangeRate":0.024937},{"month":7,"riseRate":0.4375,"avgChangeRate":0.052717},{"month":8,"riseRate":0.375,"avgChangeRate":0.111412},{"month":9,"riseRate":0.235294,"avgChangeRate":-0.12361},{"month":10,"riseRate":0.176471,"avgChangeRate":0.026317},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.04187},{"month":12,"riseRate":0.588235,"avgChangeRate":0.233742}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}